Searchable abstracts of presentations at key conferences in endocrinology

ea0064009 | Risk of Malignancy of the Thyroid Nodule Evaluated by Scintigraphy | BES2019

Risk of Malignancy of the Thyroid Nodule Evaluated by Scintigraphy

Elias De Meyst , Bert Bravenboer , Marleen Keyaerts , Steven Raeymaeckers , Brigitte Velkeniers , Corina Andreescu

Background: Thyroid nodules are a common finding in clinical practice. Among classic risk factors for thyroid cancer, thyroid scintigraphy has traditionally been attributed prognostic value, with cold nodules implying greater risk. However, research supporting this assumption is of considerable age and possibly influenced by selection bias. In this study, we aimed to calculate the risk of malignancy in cold and hot nodules.Material and Methods: All thyro...

ea0064017 | Value of [11C]-methionine PET/CT in preoperative localization of adenomas in primary hyperparathyroidism | BES2019

Value of [11C]-methionine PET/CT in preoperative localization of adenomas in primary hyperparathyroidism

Julie Saerens , Brigitte Velkeniers , Marian Vanhoeij , Marleen Keyaerts , Steven Raeymaeckers , Bert Bravenboer

Introduction: The first-line imaging modalities to locate adenomas preoperatively in primary hyperparathyroidism (PHPT) are ultrasonography (US) and subtraction scintigraphy (SuSc). When these contradict each other or are inconclusive an [11C]-methionine PET/CT (MET-PET/CT) or a 4-dimensional computed tomography (4D-CT) can be performed.Objectives: The aim of this retrospective study was to evaluate the value of MET-PET/CT in the preoperative localizatio...